RE:RE:RE:RE:RE:RE:From the Spring 2015 CXR presentation per Cohodes....SELECT.... It's not about me , it's about you being long CXR and saying its a big risk. Don't know a single investor who buys a stock , and then bashes it for weeks , saying its a big risk. As I've said you're a moron.
select1011 wrote: Ok. If you feel your investment is a sure thing with no risk, than you are free to invest accordingly.
Pj1958 wrote: SELECT.... It's a gamble for all longs including you, as you are long CXR... I don't know a single moron , that is long a stock and says its a big gamble. You are truly the biggest loser on this board.
buy high and sell low.
select1011 wrote: ...and fro my part I can add that Tribute was a roll-up that got bought up by Pozen l
ast spring, and had a failed inversion plan for Ireland, and then had to switch it for Canada early this year. Not well managed after MT left, but they bought his roll-up inversion blue print. The main point I want to stress, is that CXR was built during a chuckle head heyday when deal makers copied one idea, and with barely any delivery experience, got and spent a ton of money. With all the public scrutiny on drug price hikes, the model will continue to be crucified. The sorry thing for MT and CXR, there isn't an Ackman like equivalent, who can give the company cred. Its just MT. That's a big gamble for any retail long.
Craigbad wrote: I checked into Trimel, they changed they name to Acerus. The stock has lost near all its value and is floating at $0.18 now. Cohedes and the shorts are making big bets on MT's failure whether we like it or not based on companies he's been involved with in the past collapsing.